Cardiac Surgery for Carcinoid Heart Disease: A Weapon Not to Be Misused

Publisher： Karger

E-ISSN： 1421-9751|136|4|243-251

ISSN： 0008-6312

Source： Cardiology, Vol.136, Iss.4, 2016-11, pp. : 243-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

III. Aprotinin and cardiac surgery: a sorry tale of evidence misused

By McMullan V.   Alston R. P.   Mahajan R. P.  

BJA: British Journal of Anaesthesia, Vol. 110, Iss. 5, 2013-05 ,pp. : 675-678

Oxford University Press

Access to resources Recommend Favorite

Evaluation of carcinoid heart disease using delayed enhancement imaging

By Hrabak-Paar M.  

Irish Journal of Medical Science, Vol. 180, Iss. 2, 2011-06 ,pp. : 619-619

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Treatment with Bosentan in Patients with Carcinoid Heart Disease: Single Center Study

By  

Oncology Research and Treatment, Vol. 33, Iss. 6, 2010-05 ,pp. : 300-304

Karger

Access to resources Recommend Favorite

Carcinoid Heart Disease without Severe Tricuspid Valve Involvement

By  

Cardiology, Vol. 133, Iss. 4, 2015-12 ,pp. : 217-222

Karger

Access to resources Recommend Favorite

Comparison of the Effects of Dexmedetomidine and Propofol on Hemodynamics and Oxygen Balance in Children with Complex Congenital Heart Disease Undergoing Cardiac Surgery

By  

CONGENITAL HEART DISEASE, Vol. 10, Iss. 3, 2015-05 ,pp. : E123-E130

John Wiley & Sons Inc

Access to resources Recommend Favorite